DocGo projects FY26 revenue between $280M and $300M, below consensus estimate of $317.78M.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 10 2025
0mins
- FY26 Adjusted EBITDA Forecast: The adjusted EBITDA for FY26 is projected to be between $25 million and $15 million.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like DCGO with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on DCGO
Wall Street analysts forecast DCGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCGO is 3.13 USD with a low forecast of 1.50 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.824
Low
1.50
Averages
3.13
High
4.00
Current: 0.824
Low
1.50
Averages
3.13
High
4.00
About DCGO
DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
DocGo Expands Clinical Workforce to Meet Growing Demand
- Clinical Workforce Expansion: DocGo's SteadyMD plans to increase its clinical staff by up to 50% in the coming weeks to meet the accelerating demand for clinician-led telehealth services from top consumer and healthcare brands, thereby enhancing the company's competitive edge in the rapidly growing virtual healthcare market.
- Hiring Initiative Launch: The hiring initiative prioritizes clinicians with five or more active state licenses to support nationwide care delivery, ensuring patients receive consistent, high-quality care and further solidifying the company's market position.
- Strategic Investment Commitment: SteadyMD's co-founder Guy Friedman emphasizes that this hiring push underscores the company's commitment to building high-quality telehealth programs that meet patient and partner needs, driving sustainable growth through superior service.
- Growing Market Demand: As customer demand for branded GLP-1 weight loss treatments expands, SteadyMD's proven clinical model and national network expansion will enable DocGo to meet rising patient needs while maintaining high standards of care.
Continue Reading
DocGo CFO to Speak at 28th Annual Needham Growth Conference, Advancing Mobile Health Services
- Executive Presentation: DocGo CFO Norm Rosenberg will hold a fireside chat at the 28th Annual Needham Growth Conference on January 14, showcasing the company's innovations in mobile health, which is expected to attract investor interest and enhance market confidence.
- 1x1 Meetings: Rosenberg will also participate in one-on-one meetings at the event, aiming to engage with potential investors to further drive investment and collaboration opportunities in the healthcare technology sector.
- Technology-Driven Care: DocGo's mobile health services and remote patient monitoring platform, combined with proprietary technology and certified health professionals, elevate patient care quality, which is anticipated to strengthen the company's competitive position in the healthcare services market.
- Market Positioning: By integrating mobile health with medical transport services, DocGo is reshaping the traditional healthcare system, expected to attract more clients by enhancing service accessibility and reducing costs, thereby driving long-term growth.
Continue Reading